Biography:
Sergey Suchkov graduated from Astrakhan State Medical University and awarded with MD, then in 1985 maintained his PhD at the Sechenov University and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was at Koltzov Inst of Developmental Biology. From 1989 through 1995, he was a Head of the Lab of Clin Immunology, Helm-holtz Eye Res Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clin Immunology, MONIKI. Dr Suchkov has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Edit Board, Biomedical Science, an Int Journal published jointly by the USSR Acade-my of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is a Chair, Dept for Personalized Medicine, Preci-sion Nutriciology and Biodesign at the Institute for Biotech & Global Health of RosBioTech and Professor of the Dept for Clinical Immu-nology of A.I. Evdokimov MGMSU, Russia. He is a member of the: New York Academy of Sciences, American Chemical Society (ACS), American Heart Association (AHA), EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Research in Vision and Ophthalmology); ISER (International Society for Eye Research); PMC (Personal-ized Medicine Coalition), Washington, USA.
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biotech, bioindustry and personalized and precision medical practice
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired biotech-driven translational applications and upgraded business marketing to secure the human healthcare, wellness and biosafety
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety